Banque Cantonale Vaudoise’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,303
Closed -$150K 1211
2020
Q4
$150K Sell
1,303
-31
-2% -$3.47K 0.01% 780
2020
Q3
$130K Buy
1,334
+5
+0.4% +$575 0.01% 783
2020
Q2
$163K Sell
1,329
-43
-3% -$4.88K 0.01% 699
2020
Q1
$120K Sell
1,372
-28
-2% -$2.96K 0.01% 739
2019
Q4
$146K Buy
+1,400
New +$157K 0.01% 763

Other funds holding GWPH

Banque Cantonale Vaudoise's GWPH Position: Q1 2021 in Review

Banque Cantonale Vaudoise sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 1,303 shares — an estimated $150K sold.

Banque Cantonale Vaudoise first reported a position in GWPH in Q4 2019 and held it in 5 quarters. The position peaked at $163K in Q2 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Banque Cantonale Vaudoise reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 1,303 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $150K.
  • Banque Cantonale Vaudoise first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 5 quarters.
  • Banque Cantonale Vaudoise's GW Pharmaceuticals Plc American Depositary Shares position peaked at $163K in Q2 2020.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2021, filed 11 May 2021.